NDC 49396-0050 - Enbumyst
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 49396-0050
- Package NDCs from labels
- 49396-0050-6, 49396-0050-2
- Manufacturer
- Renaissance Lakewood LLC
- Effective date
- 2025-11-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Bumetanide Nasal Spray - Renaissance Lakewood LLC | Renaissance Lakewood LLC | 2025-11-20 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| bumetanide | BUMETANIDE | Zydus Pharmaceuticals (USA) Inc. | 525138cd-832a-41d0-84b0-83921b12bd2a | 2023-12-05 | Boxed warning, Warnings, Adverse reactions | 0Y2S3XUQ5H |
| bumetanide | BUMETANIDE | Zydus Lifesciences Limited | 82eb62ca-c32b-4ff8-9f71-43219b240480 | 2023-12-05 | Boxed warning, Warnings, Adverse reactions | 0Y2S3XUQ5H |
| bumetanide | BUMETANIDE | A-S Medication Solutions | cf29e436-b630-4b03-bb9b-9267ae77dc00 | 2023-11-01 | Boxed warning, Warnings, Adverse reactions | 0Y2S3XUQ5H |
| Bumetanide | BUMETANIDE | Sandoz Inc | 05cb961d-ac33-4bcf-b04e-411e496c43c1 | 2023-06-30 | Boxed warning, Warnings, Adverse reactions | 0Y2S3XUQ5H |
| Bumetanide | BUMETANIDE | Civica, Inc. | 308c690f-c2bd-4c32-8728-42ec95425f77 | 2023-04-07 | Boxed warning, Warnings, Adverse reactions | 0Y2S3XUQ5H |
| Bumetanide | BUMETANIDE | A-S Medication Solutions | 7f9dccf8-37ff-454b-9d55-7f1d631c8483 | 2023-01-25 | Boxed warning, Warnings, Adverse reactions | 0Y2S3XUQ5H |
| Bumetanide | BUMETANIDE | GLENMARK PHARMACEUTICALS INC., USA | 680563fe-5d3a-49bc-86a5-740bda2acebe | 2023-01-09 | Boxed warning, Warnings, Adverse reactions | 0Y2S3XUQ5H |
| Bumetanide | BUMETANIDE | A-S Medication Solutions | f6ff0d37-c67d-4b9f-8b62-5deda9783c28 | 2023-01-05 | Boxed warning, Warnings, Adverse reactions | 0Y2S3XUQ5H |
| Bumetanide | BUMETANIDE | A-S Medication Solutions | 8bed63fb-91ec-4132-ac0a-16c4c6f58d95 | 2023-01-03 | Boxed warning, Warnings, Adverse reactions | 0Y2S3XUQ5H |
| Bumetanide | BUMETANIDE | Fresenius Kabi USA, LLC | a007f3aa-3977-4be3-a9a2-db3d458bca58 | 2022-09-19 | Boxed warning, Warnings, Adverse reactions | 0Y2S3XUQ5H |
| Bumetanide | BUMETANIDE | Novadoz Pharmaceuticals LLC | 387edfd4-be85-41cd-8a6d-14e6a022b5a9 | 2022-08-09 | Boxed warning, Warnings, Adverse reactions | 0Y2S3XUQ5H |
| Bumetanide | BUMETANIDE | Gland Pharma Limited | 4d1ed6b2-c410-4f52-9b8a-aa256c37089e | 2022-06-01 | Boxed warning, Warnings, Adverse reactions | 0Y2S3XUQ5H |
| Bumetanide | BUMETANIDE | Aphena Pharma Solutions - Tennessee, LLC | 7e47e7b1-d28a-4e12-882f-cf193b7f2697 | 2019-09-30 | Boxed warning, Warnings, Adverse reactions | 0Y2S3XUQ5H |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.